Alterations of oprd in carbapenem-intermediate and -susceptible strains of pseudomonas aeruginosa isolated from patients with bacteremia in a spanish multicenter study
Antimicrobial Agents and Chemotherapy, 04/06/2012
Clinical Article
Ocampo–Sosa AA et al. – Authors concluded that OprD inactivating mutations in clinical isolates of P. aeruginosa are not restricted only to carbapenem–resistant isolates but are also found in isolates with imipenem or meropenem MICs of only 0.06 to 4 μg/ml.



